Pragmatic Kappos brings USPTO claims and continuations litigation to an end
You can file this away in the "It should have happened a long time ago" file. Yesterday GlaxoSmithKline and the US Patent and Trademark Office announced that they would be submitting a motion to dismiss litigation concerning the controversial claims…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.